BackBrookdale Senior Living Overview
Brookdale Senior Living Inc

Brookdale Senior Living Target Price

See Brookdale Senior Living's analyst price targets ($22) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.98

Average Target Price

$22.0069.5% upside

1 analysts in the last 4 months

High: $22 | Low: $22

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-15Compass Point$2269.5% upsideOpen
2026-04-08Stephens$1838.7% upsideOpen
2026-02-03Barclays$1838.7% upsideOpen
2026-01-29RBC Capital$1731% upsideOpen
2026-01-22BarclaysAndrew Mok$1515.6% upsideOpen
2025-11-17RBC Capital$130.2% upsideOpen
2025-11-10BarclaysAndrew Mok$147.9% upsideOpen
2025-08-07BarclaysAndrew Mok$838.4% downsideOpen
2025-04-01BarclaysAndrew Mok$746.1% downsideOpen
2024-10-16JefferiesBrian Tanquilut$838.4% downsideOpen
2023-07-12RBC CapitalBen Hendrix$746.1% downsideOpen

Brookdale Senior Living (BKD) FAQ

The latest target price for BKD is $22. Investors often review this figure alongside Brookdale Senior Living's historical trend and sector peers before judging valuation or financial health.

Brookdale Senior Living trades near $12.98 while the consensus target sits at $22 (69.5% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting BKD's target price ($22), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Brookdale Senior Living's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.